GlaxoSmithKline News

Lambert, Steve - The provinces are being asked to hold back a batch of swine flu vaccine that appears to be causing higher rates of severe allergic reactions.

Canada's H1N1 flu vaccine manufacturer has asked the provinces to temporarily discontinue vaccinating Canadians from a lot of vaccine shipped in October due to a higher risk of adverse reactions, says a Manitoba health official.

Anacor Pharmaceuticals today announced that it has dosed the first patient in a Phase I clinical study for AN3365, a novel boron-based, small-molecule drug candidate in development for the treatment of hospital infections caused by Gram-negative bacteria.

Main Category: Smoking / Quit Smoking Also Included In: Pharma Industry / Biotech Industry An experimental vaccine called NicVAX, designed to treat nicotine addiction that works by stopping the drug from reaching the brain, moved a step closer to the market when the vaccine developer Nabi Biopharmaceuticals , based in Rockville, Maryland, US agreed ...

ANI ANI Soon, an injectable vaccine to help kick the butt Good news for smokers struggling to quit: an injectable vaccine has been developed that may help them kick the habit.

In this undated photo provided by Sanofi Pasteur, technicians perform production operations during a dry run at the company's influenza manufacturing facility in Swiftwater, Pa.

Investment bank Lazard Tuesday named Kenneth Jacobs, 51, its new chairman and chief executive, replacing Bruce Wasserstein, who unexpectedly died last month.

Has the tide turned against states in their drug pricing suits against Big Pharma? Last month, we reported on a landmark ruling from the Alabama Supreme Court that threw out more than $270 million in verdicts against Novartis, GlaxoSmithKline and AstraZeneca, which had been found liable for overcharging the state Medicaid system for drugs.

Nabi Biopharmaceuticals and a division of GlaxoSmithKline said Monday they have entered an option and licensing agreement over an investigational vaccine for the treatment of nicotine addiction.

Main Category: Swine Flu Also Included In: Immune System / Vaccines ; Aid / Disasters Article Date: 11 Nov 2009 - 4:00 PST Drugmaker GlaxoSmithKline announced plans on Tuesday to donate 50 million doses of its H1N1 vaccine to the WHO for use in developing countries within the next few months, Reuters reports.

"This is literally a life-and-death issue that must be handled with great care." -- Celgene spokesman Brian Gill, as quoted in The Wall Street Journal .

In asthmatic children, treatment with fluticasone plus salmeterol is associated with fewer serious exacerbations and lower medical costs compared to the use of an inhaled corticosteroid plus montelukast.

Correspondence to the Lancet two weeks ago revealed another instance in which clinical research studies that failed to provide results favorable to a sponsor's product were suppressed.

Clinics and doctors across the country were given the green light Friday to start using 1.8 million doses of H1N1 vaccine made without adjuvant - but they were told not to give it to one of the originally intended recipient groups.

Nov. 11 Federal Food and Drug Administration Commissioner Margaret Hamburg, M.D., has posted an open letter praising doctors, nurses, and other health professionals for their 'extraordinary efforts' in responding to the 2009 H1N1 influenza outbreak, for which 41 million doses of vaccine has been allocated to the states with more becoming available ...

Cambridge, UK, 12th November 2009. Astex Therapeutics Limited announced today that it has entered into a new collaboration agreement with GlaxoSmithKline to discover, develop and commercialise novel compounds directed against multiple therapeutic targets of interest to GSK.

Canada is not moving too slowly on the production and approval of the H1N1 flu vaccine, the countrya TMs chief public health officer said Tuesday.

Two hundred and fifty workers in Sligo are today coming to terms with the news that their jobs are gone, with the closure of Stiefel Laboratories.

As federal regulators take their first tentative steps toward policing the wild west of medical information online, pharmaceutical companies are pressing their case to market drugs via Google, Twitter and other Web sites.

Main Category: HIV / AIDS Also Included In: Clinical Trials / Drug Trials Article Date: 11 Nov 2009 Concert Pharmaceuticals, Inc.